✦ LIBER ✦

Herpes simplex and varicella-zoster virus infections during pregnancy: current concepts of prevention, diagnosis and therapy. Part 1: Herpes simplex virus infections

✍ Scribed by A. Sauerbrei; P. Wutzler

Publisher: Springer-Verlag
Year: 2006
Tongue: English
Weight: 289 KB
Volume: 196
Category: Article
ISSN: 0300-8584
DOI: 10.1007/s00430-006-0031-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Herpes simplex and varicella-zoster viru

Herpes simplex and varicella-zoster virus infections during pregnancy: current concepts of prevention, diagnosis and therapy. Part 2: Varicella-zoster virus infections

✍ A. Sauerbrei; P. Wutzler 📂 Article 📅 2006 🏛 Springer-Verlag 🌐 English ⚖ 306 KB

Reactivity of varicella-zoster virus sub

Reactivity of varicella-zoster virus subunit antigens in enzyme-linked immunosorbent assay to sera from varicella, zoster, and herpes simplex virus infections

✍ Michiko Takayama 📂 Article 📅 1994 🏛 Springer-Verlag 🌐 English ⚖ 676 KB

Serological responses to varicella-zoster virus (VZV) subunit antigens, such as capsid, envelope, and soluble (S) antigens, in patients with VZV and herpes simplex virus (HSV) infections were studied by comparing with responses to virion (V) antigens using an enzyme-linked immunosorbent assay (ELISA

Oral bromovinyldeoxyuridine therapy for

Oral bromovinyldeoxyuridine therapy for herpes simplex and varicella-zoster virus infections in severely immunosuppressed patients: A preliminary clinical trial

✍ G. Tricot; Prof. E. De Clercq; M. A. Boogaerts; R. L. Verwilghen 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 556 KB

Twenty-five patients with haematological diseases were treated orally with the highly potent and selective anti-herpes agent, bromovinyldeoxyuridine (BVDU), in a dosage of 7.5 mglkglday (divided over three or four doses a day) for 5 days for an intercurrent mucocutaneous herpesvirus infection. Of th

Identification of ribosome-associated vi

Identification of ribosome-associated viral and cellular basic proteins during the course of infection with herpes simplex virus type 1

✍ Anna Greco; Willy Bienvenut; Jean-Charles Sanchez; Karine Kindbeiter; Denis Hoch 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB 👁 2 views

Influence of 1-dodecylazacycloheptan-2-o

Influence of 1-dodecylazacycloheptan-2-one (azone) on the topical therapy of cutaneous herpes simplex virus type 1 infection in hairless mice with 2′,3′-di-o-acetyl-9-β-D-arabinofuranosyladenine and 5′-O-vaieryl-9-β-D-arabinofuranosyladenine

✍ W. M. Shannon; L. Westbrook; W. I. Higuchi; K. Sugibayashi; D. C. Baker; S. D. K 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 447 KB